Candidates for the 2023-2024 Executive Committee

NABP is pleased to announce the following individuals as nominees for open officer and member positions on NABP’s 2023-2024 Executive Committee. Elections will be held in May 2023 during the 119th Annual Meeting for the following positions:

  • President-Elect (one-year term)
  • Treasurer (one-year term)
  • Member, District 1 (two-year term)
  • Member, District 3 (three-year term)
  • Member, District 4 (three-year term)
  • Member, District 8 (three-year term)

All eligible individuals will be placed on the ballot.

Officer Nominations

Headshot of Jeffrey Mesaros
Jeffrey J. Mesaros, PharmD, JD, RPh, Florida Nominee for President-Elect (one-year term)

NABP continues to change and adapt to the directions and initiatives advocated by the member boards of pharmacy. As President-Elect, what new areas do you foresee NABP undertaking in order to support its member boards in the years ahead?

NABP has established a strong foundation of supporting member boards in protecting the public health through innovation and collaboration. As patients use emerging modalities to access care, pharmaceutical manufacturers develop treatments for complex disease states, and pharmacists, pharmacy technicians and pharmacies continue to provide care in ways we previously have not or could not, member boards will be asked to evaluate their laws and rules. As President-Elect, I foresee NABP providing support in the areas of evolving practice models and health care technologies and in the role of manufacturers in patient-centered care. I believe NABP is well positioned to assist our member boards in these areas as they work diligently to keep the patients of their state safe as access to care and treatments evolves.


Bradley S. Hamilton, BSPharm, RPh, Maine Nominee for Treasurer (one-year term)

The volatile economic market, defined by domestic struggles and global trade wars, creates a difficult financial landscape for managing resources and investments. If elected Treasurer of NABP, what do you recommend is the best way to continue to grow NABP’s resources without raising fees?

If elected Treasurer, I would ensure our financial goals align with fiscal duties and outline a clear strategy to achieve results. I would continue to focus on existing customers by adding complimentary services or bundling products while delivering on our pricing strategy, leveraging effective marketing strategies that drive our strategic plans, and implementing cost saving measures. I would also look to grow new customers, resources, and market share. I would maximize accreditation and inspection services, licensure services (eLTP, exam eligibility service, NABP Verify, Emergency Passport Program) and industry information network offerings like Pulse, by NABP, and PMP InterConnect. Leveraging these responsibilities will grow resources without raising fees.


Member Nominations

The following candidates have been nominated for the Executive Committee member positions by their districts at the respective district meetings.

Stacey Ranucci, RPh, BGCP, CDCES, CDOE, FASCP, Rhode Island Nominee for the District 1 Open Member Position on the Executive Committee (two-year term)

The expansion of the pharmacist’s role to provide and improve patient care has been under consideration for some time. As a member of the Executive Committee, what regulatory initiatives should state boards of pharmacy and NABP undertake to support such efforts solely in the interest of protecting the public health?

The current practice of pharmacy has various social and health implications to different cohorts of people. Public health strategies to improve overall health in populations has historically been successful when we meet patients where they live and work. Pharmacists are well positioned to bridge the gap and assist providers with managing chronic diseases, reduce health disparities, and advance health equities across all neighborhoods and regions. Interventions to increase access to health care providers and improve communication can help people get the appropriate medical care and pharmaceutical care needed in a timely manner. As a member of the Executive Committee of NABP, I will encourage, develop, and support patient accessibility to health information by pharmacists across all practice settings.


Headshot of Traci Collier
Traci Collier, PharmD, RPh, South Carolina Nominee for the District 3 Open Member Position on the Executive Committee (three-year term)

The expansion of the pharmacist’s role to provide and improve patient care has been under consideration for some time. As a member of the Executive Committee, what regulatory initiatives should state boards of pharmacy and NABP undertake to support such efforts solely in the interest of protecting the public health?

In today’s complex health care environment, access is often an issue for patients. Allowing pharmacists to test to treat for minor ailments is one of the most effective ways to increase access and improve outcomes for patients. We are the most accessible health care professionals and also the most knowledgeable drug experts of any profession. Studies have shown numerous benefits of pharmacist care, including improved adherence, resulting in better patient outcomes. Numerous outdated state regulations addressing pharmacists’ scope of practice in this area, are undeniably one of the most difficult barriers to overcome. Expanding the pharmacists’ role to provide this service, for which they are trained and qualified, would greatly increase access for patients and go a long way toward protecting public health.


Steven W. Schierholt, Esq, Ohio Nominee for the District 4 Open Member Position on the Executive Committee (three-year term)

The expansion of the pharmacist’s role to provide and improve patient care has been under consideration for some time. As a member of the Executive Committee, what regulatory initiatives should state boards of pharmacy and NABP undertake to support such efforts solely in the interest of protecting the public health?

As one of the most trusted health care professionals, the role of the pharmacist is critical to ensure safe and equitable access to health care. I fully support expanding access to reimbursable, pharmacist-led services such as MOUD [medications for opioid use disorder] and test-and-treat programs, and permitting syringe access via pharmacies. Additionally, we must also recognize that any additional responsibilities given to pharmacists must come with support from state regulators to reduce burnout and workplace stress. Therefore, I support efforts at the state and national level to address workplace stressors on pharmacy staff that pose a potential risk to the public health.


Mark Smosna, RPh, Indiana Nominee for the District 4 Open Member Position on the Executive Committee (three-year term)

The expansion of the pharmacist’s role to provide and improve patient care has been under consideration for some time. As a member of the Executive Committee, what regulatory initiatives should state boards of pharmacy and NABP undertake to support such efforts solely in the interest of protecting the public health?

As a member of the Executive Committee, I will be of the mindset that we need to transition from a transactional model to a patient care model to advance the profession of pharmacy. We have seen this shift with pharmacists performing clinical services such as MTM and immunizations. We need to remove barriers that prevent future role expansion by supporting our various state boards of pharmacy through legislative change. One way of doing so is by boards of pharmacy removing regulations that are no longer applicable and inhibit innovation of pharmacy practice while keeping patient safety at the forefront. The development of a standard of care model would allow a pharmacist to engage in pharmacy practices as long as it falls within their training, education, and practice experience.


Headshot of Kam Gandhi
Kamlesh “Kam” Gandhi, PharmD, RPh, Arizona Nominee for the District 8 Open Member Position on the Executive Committee (three-year term)

The expansion of the pharmacist’s role to provide and improve patient care has been under consideration for some time. As a member of the Executive Committee, what regulatory initiatives should state boards of pharmacy and NABP undertake to support such efforts solely in the interest of protecting the public health?

Having access to health care along with improving the quality of health care is part of protecting the public. The best kept secret is the ability of a pharmacist to practice at the top of their education. The education and knowledge that a pharmacist has outweighs other professions that are engaged with assessing and diagnosing a patient’s medical condition. As an Executive Committee member, I would like to see NABP engaged in an educational campaign targeting lawmakers. The bar for health care needs to be brought back to a higher standard and pharmacists are capable of doing that.